Congress should start a $15 billion, budget-neutral, space-race-like, winner-takes-most competition that uses our economic system’s best weapons --- entrepreneurship, private financing, and the competitive marketplace. The government just primes the pump.
How it would work:
Our goal is to create a technology that allows people to grow new kidneys.
What is needed is a federal effort that boosts current research in the small,
but growing scientific fields of bioartificial and regenerative medicine.
To do this, the U.S. government should first announce a competition where
the winner will get a huge, monetary prize for curing ESRD ($5 billion).
That will get a lot of media attention. To encourage competition and a variety
of approaches, up to 10 companies and/or institutions are allowed to begin
competing for the prize. After a successful application screening, each
competing group gets $100 million for its first year's work. Every year,
some groups would likely drop out because they had taken the wrong paths
and approaches. If none of them dropped out, then the one or two programs
showing the least promise would be eliminated each year. The remaining groups
in the competition would continue to get yearly grants of $100 million or
more. These groups could seek out additional private financing at any time.
If it is eliminated from the official competition, that group could merge
into one of the survivors or seek its own private financing for any direction
it wanted to go. As the competition progressed, the surviving groups could
also combine efforts or make deals to collaborate. The eventual winner gets
a $5 billion grand prize. Over the years, the annual grants to the competing
groups and the administration of the competition would cost an additional
$5-10 billion.
Another beauty of this process is that it would force these groups to operate as economically, efficiently, and fast as possible. As for the intellectual property that will be created, the companies could own it, but the U.S. government would share in a small percentage of the gross sales revenues for any products and/ services that result, as well as any associated patent royalties. Perhaps some of these revenues could then be used to fund similar competitions for other diseases.
Just like the 1960's space exploration program, I'm sure that there will be numerous collateral discoveries and products coming out of their work that will benefit other branches of medicine, science, and society in general.
We can fund this competition
by taking a commonsense approach to ESRD IV drug reimbursement. The drug
companies should make profits that are very healthy, but not obscene. The
total costs of this competition can be made budget-neutral for the federal
government over its lifespan and it will, of course, end up saving hundreds
of billions of taxpayer dollars in the coming decades.
We need to take the Center for Medicare and Medicaid Services's (CMS) latest
10-year budget projections for ESRD drug costs, subtract $15 billion, and
then decide how to spread this "pain" fairly among the drug companies.
Put another way, Congress should lower the Medicare ESRD drug reimbursements
to more reasonable amounts, have these payments go directly to the drug
companies, and then use the savings to fund this competition.
And just what’s wrong with this idea?
Oh yeah, now I remember what’s wrong with this idea. The drug companies would make a little less money and would lose long-term customers.
Who will our Congress, our elected representatives, listen to? Well, for an example, view Amgen's contributions to political campaigns at www.tray.com. Type in "Amgen" in the 'Go Search' box, click on the button for the '2006, 2004, 2002 combined (takes a bit longer...)' election cycle, and then click "Go Search".
Well, hey China! Here’s another idea that
you can use to take over yet another sector of the world economy that America
currently leads.
This web site has been set up to facilitate a grass-roots effort to cure ESRD.
The web site will be updated continuously with news, statements of support,
supporting statistical data, economic data, etc. If you are interested in contributing
information, graphics, a statement of support, or notifying your congresspeople,
please do so through the links provided here.
